^a Tested in dextrose 5%.

^b Tested in sodium chloride 0.9%.

^c Tested in both dextrose 5% and sodium chloride 0.9%.

^d Tested in dextrose 5% with albumin human 2 mg/mL.

^e Tested as the premixed infusion solution.

^f Lyophilized formulation tested.

^g Refer to Appendix for the composition of parenteral nutrition solutions. TNA indicates a 3-in-1 admixture, and TPN indicates a 2-in-1 admixture.

^h A 32.5-mL sample of parenteral nutrition solution mixed with 50 mL of antibiotic solution.

ⁱ Run at 21 mL/hr.

^j Given over 30 minutes by syringe pump.

^k Run at 94 mL/hr.

^l Run at 10 mL/hr.

^m Given over one hour by syringe pump.

ⁿ Sulbactam component. Sulbactam in a 1:1 fixed-ratio concentration with durlobactam.

^o Tested in Ringer’s injection, lactated.

^p Injected via Y-site into an administration set running azithromycin.

^q Tested in sterile water for injection.

^s Tested in a 1:1 mixture of (1) dextrose 5% and dextrose 5% in sodium chloride 0.45% with and without potassium chloride 20 mEq/L and also in (2) dextrose 10% in sodium chloride 0.45% with and without potassium chloride 20 mEq/L.

^t Test performed using the formulation WITHOUT edetate disodium.

^u Test performed using the formulation WITH edetate disodium.

^v Ceftolozane component. Ceftolozane in a 2:1 fixed-ratio concentration with tazobactam.

^w Meropenem component. Meropenem in a 1:1 fixed-ratio concentration with vaborbactam.

^x Ceftazidime component. Ceftazidime in a 4:1 fixed-ratio concentration with avibactam.

^y Tested in both dextrose 5% and Ringer’s injection, lactated.

^z Salt not specified.

^aa Imipenem component. Imipenem in a 2:2:1 fixed-ratio concentration with relebactam.